NEA Management Company’s Trevi Therapeutics TRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $72.3M | Buy |
13,222,228
+1,851,852
| +16% | +$10.1M | 5.44% | 6 |
|
|
2025
Q1 | $71.5M | Hold |
11,370,376
| – | – | 5.51% | 6 |
|
|
2024
Q4 | $48.8M | Hold |
11,370,376
| – | – | 2.76% | 11 |
|
|
2024
Q3 | $38M | Hold |
11,370,376
| – | – | 2.07% | 12 |
|
|
2024
Q2 | $33.9M | Hold |
11,370,376
| – | – | 2.55% | 10 |
|
|
2024
Q1 | $39.2M | Hold |
11,370,376
| – | – | 2.44% | 12 |
|
|
2023
Q4 | $15.2M | Hold |
11,370,376
| – | – | 1.02% | 20 |
|
|
2023
Q3 | $24.8M | Hold |
11,370,376
| – | – | 1.91% | 16 |
|
|
2023
Q2 | $27.2M | Hold |
11,370,376
| – | – | 2.07% | 16 |
|
|
2023
Q1 | $21M | Sell |
11,370,376
-2,798
| -0% | -$5.18K | 1.45% | 20 |
|
|
2022
Q4 | $22M | Hold |
11,373,174
| – | – | 1.23% | 22 |
|
|
2022
Q3 | $17.5M | Hold |
11,373,174
| – | – | 0.87% | 30 |
|
|
2022
Q2 | $32M | Buy |
11,373,174
+11,370,376
| +406,375% | +$32M | 1.64% | 14 |
|
|
2022
Q1 | $17.1M | Sell |
2,798
-5,937,998
| -100% | -$36.4B | 0.5% | 29 |
|
|
2021
Q4 | $4.63M | Hold |
5,940,796
| – | – | 0.09% | 52 |
|
|
2021
Q3 | $8.32M | Hold |
5,940,796
| – | – | 0.1% | 53 |
|
|
2021
Q2 | $13.4M | Hold |
5,940,796
| – | – | 0.17% | 50 |
|
|
2021
Q1 | $16.1M | Hold |
5,940,796
| – | – | 0.36% | 44 |
|
|
2020
Q4 | $14.4M | Hold |
5,940,796
| – | – | 0.38% | 42 |
|
|
2020
Q3 | $23.9M | Hold |
5,940,796
| – | – | 1.01% | 25 |
|
|
2020
Q2 | $39.1M | Buy |
5,940,796
+1,499,436
| +34% | +$9.87M | 1.57% | 17 |
|
|
2020
Q1 | $14.6M | Hold |
4,441,360
| – | – | 0.76% | 22 |
|
|
2019
Q4 | $16.7M | Hold |
4,441,360
| – | – | 0.79% | 22 |
|
|
2019
Q3 | $20M | Buy |
4,441,360
+11,556
| +0.3% | +$52K | 1.65% | 19 |
|
|
2019
Q2 | $33.2M | Buy |
+4,429,804
| New | +$33.2M | 2.33% | 17 |
|